Modeling hippocampal neurogenesis using human pluripotent stem cells.
- Authors
- Yu, Diana Xuan; Di Giorgio, Francesco Paolo; Yao, Jun; Marchetto, Maria Carolina; Brennand, Kristen; Wright, Rebecca; Mei, Arianna; McHenry, Lauren; Lisuk, David; Grasmick, Jaeson Michael; Silberman, Pedro; Silberman, Giovanna; Jappelli, Roberto; Gage, Fred H
- Year
- 2014
- Journal
- Stem cell reports
- PMID
- 24672753
- DOI
- 10.1016/j.stemcr.2014.01.009
- PMCID
- PMC3964286
The availability of human pluripotent stem cells (hPSCs) offers the opportunity to generate lineage-specific cells to investigate mechanisms of human diseases specific to brain regions. Here, we report a differentiation paradigm for hPSCs that enriches for hippocampal dentate gyrus (DG) granule neurons. This differentiation paradigm recapitulates the expression patterns of key developmental genes during hippocampal neurogenesis, exhibits characteristics of neuronal network maturation, and produces PROX1+ neurons that functionally integrate into the DG. Because hippocampal neurogenesis has been implicated in schizophrenia (SCZD), we applied our protocol to SCZD patient-derived human induced pluripotent stem cells (hiPSCs). We found deficits in the generation of DG granule neurons from SCZD hiPSC-derived hippocampal NPCs with lowered levels of NEUROD1, PROX1, and TBR1, reduced neuronal activity, and reduced levels of spontaneous neurotransmitter release. Our approach offers important insights into the neurodevelopmental aspects of SCZD and may be a promising tool for drug screening and personalized medicine.
Generation of Hippocampal Granule Neurons from hESCs Using Embryoid Bodies(A) Schematic representation of the differentiation paradigm for generating hippocampal granule neurons using free-floating embryoid bodies (EBs).(B) Immunostaining of EB cross sections at differentiation day 35 showed the presence of PROX1 with TUJ1 and MAP2AB. Scale bar, 100 ΞΌm.(C) Quantification of PROX1+ immunostaining in EBs at differentiation day 35 showed a higher percentage of PROX1+ nuclei in EBs treated with cocktail of factors. n = 3 biological replicates; two-tailed t-test.(D) qPCR for OCT4 expression in control and treated EBs over time.(E) qPCR for PROX1 expression in control and treated EBs over time.(F) Expression patterns of genes EMX2, PAX6, FOXG1, and NEUROD1 found in hippocampal neural progenitors.(G) Expression patterns of genes DCX and TBR1 found in the immature and mature hippocampal granule neurons.(H) Immunostaining of hippocampal granule neurons dissociated from EBs at differentiation day 40 and cocultured with hippocampal astrocytes for 4 weeks. Scale bar, 15 ΞΌm.(I) Quantification of immunostaining in 4-week cocultures showed an increased number of PROX1+ neurons in treated cultures.βp < 0.05; ββp < 0.01. In (C) and (I), n = 3 biological replicates; two-tailed t test. In (D)β(G), n = 3 biological replicates; two-way ANOVA and Bonferroni post hoc test. All data are presented as mean Β± SEM.
Generation of Hippocampal Granule Neurons from hESCs Using Monolayer Neural Progenitor Cells(A) Schematic representation of the differentiation paradigm for generating hippocampal granule neurons using neural progenitor cells (NPCs).(B) Representative images showing the presence of FOXG1, PAX6, and SOX2 in hESC-derived hippocampal NPCs compared to pan-neuronal NPCs generated without a cocktail of factors. Scale bar, 20 ΞΌm.(C) qPCR showing increased levels of PAX6, FOXG1, and EMX2 in hESC-derived hippocampal NPCs.(D) Representative image and quantification of PROX1+ neurons at differentiation week 5. Scale bar, 30 ΞΌm.(E) qPCR for expression pattern of genes relevant to hippocampal neurogenesis.(F) Representative image and quantification of GABAergic neurons at differentiation week 5. Scale bar, 30 ΞΌm.(G) Representative image and quantification of glutamatergic neurons at differentiation week 5Scale bar, 30 ΞΌm. (Gβ²) High-magnification image of vGLUT puncta on a Map2+ dendrite. Scale bar, 3 ΞΌm.βp < 0.05, ββp < 0.01. In (D), n = 3 biological replicates, two-tailed t test. In (C), (F), and (G), n = 3 biological replicates. In (E), n = 3 biological replicates; two-way ANOVA and Bonferroni post hoc test. All data are presented as mean Β± SEM.
Whole-Cell Patch-Clamp Recordings of hESC-Derived Hippocampal Granule Neurons at Differentiation Week 4(AβD) The majority of the neurons patched (eight out of ten) showed Na+/K+ currents (A) and evoked action potentials (C) as well as spontaneous bursts of action potentials (B) and spontaneous postsynaptic currents (D).(E and F) Quantification of the frequency and amplitude of spontaneous postsynaptic currents in hESC-derived hippocampal granule neurons at 4 weeks postdifferentiation.All data are presented as mean Β± SEM.
Calcium Imaging of hESC-Derived Hippocampal Granule Neurons at Differentiation Week 3 and Week 6(A) Representative image of field of neurons used for calcium imaging. Scale bar, 50 ΞΌm.(B) The percentage of active neurons and frequency of calcium transients significantly increased from week 3 to week 6, indicating formation and maturation of neuronal networks.(C and D) Pharmacological perturbation of the neuronal networks showed increased sensitivity to CNQX and GABA but reduced sensitivity to APV from week 3 to week 6.(EβH) Representative traces of intracellular calcium in response to pharmacological perturbations at week 3 and week 6.βp < 0.05; ββp < 0.01. In (B)β(D), n = 15 and 16 movies (1,026 and 1,392 neurons) for 3 weeks and 6 weeks, respectively; two-tailed t test. All data are presented as mean Β± SEM.
Transplantation of Hippocampal NPCs into Dentate Gyrus of P14 NOD-SCID Mice(A) Grafted GFP+ NPCs gave rise to neurons integrated into the endogenous granule cell layer (GCL) of the DG. Scale bar, 100 ΞΌm.(B and C) Graft-derived neurons in the GCL are positive for neuronal markers Tuj1 and Prox1 and human antigen marker HuNu. Scale bar, 50 ΞΌm; n = 3 animals.(D) Graft-derived neurons extended processes along the endogenous mossy fiber path to CA3 region. Scale bar, 50 ΞΌm.(E) Na+/K+ currents of grafted neurons in voltage clamp.(F) Evoked action potentials in response to somatic current injection.(G) Trace showing spontaneous postsynaptic currents in grafted neurons.(H) Trace showing excitatory postsynaptic currents in grafted neurons in response to stimulation at perforant path. The response can be blocked by 10 ΞΌM CNQX.(I) Representative morphology of graft-derived neurons at week 2 posttransplantation.(J) Representative morphology of graft-derived neurons at week 6 posttransplantation. Scale bar, 10 ΞΌm.(K) Morphometric analysis of graft-derived neurons showing increased soma size and total dendritic lengths between week 2 and week 6 posttransplantation.(L) Morphometric analysis of graft-derived neurons showing an increased number of dendritic segments and a similar number of dendritic trees between week 2 and week 6 posttransplantation.βp < 0.05; ββp < 0.01. n = 16 neurons traced; two-tailed t test. All data are presented as mean Β± SEM.
Reduced Levels of Hippocampal Neurogenesis from SCZD NPCs(AβC) qPCR for genes expressed in hippocampal NPCs revealed comparable levels of EMX2 and PAX6 but reduced levels of FOXG1 in SCZD hiPSC lines differentiated using the EB method.(DβF) PCR for genes expressed in hippocampal granule neurons showed reduced levels of NEUROD1, PROX1, and TBR1 in SCZD hiPSC lines differentiated using the EB method.(G and H) Representative images of immunostaining for Prox1+ neurons dissociated from EBs at differentiation day 40 and cocultured with hippocampal astrocytes for 4 weeks. Scale bar, 50 ΞΌm.(I) Pseudocolored images showing increases in florescent intensities of Fluo-4AM calcium indicator in control and SCZD neural networks. Scale bar, 50 ΞΌm.(J) The number of neurons with calcium transients is normalized to the total neurons imaged in each field of view as indicated with lentiviral synapsin/red fluorescent protein. The percentage of active neurons significantly decreased in SCZD neural networks.βp < 0.05; ββp < 0.01. In (A)β(F), n = 4 SCZD lines and 4 control lines with three biological replicates done for each line, two-way ANOVA and Bonferroni post hoc test. In (J), βp < 0.05, n = 4 SCZD lines and 4 control lines, n = 20 and 22 wells imaged for SCZD and control lines (four to seven wells per line), respectively; two-tailed t test. Data are presented as mean Β± SEM.
Attenuated Spontaneous Neurotransmitter Release in SCZD Neurons(A and B) Fluorescence micrographs of representative control (A) and SCZD (B) neurons labeled with the PROX1-EGFP lentiviral vector. Scale bar, 15 ΞΌm.(CβF) Electrophysiological properties of control and SCZD neurons; transient Na+ currents and sustained K+ currents in response to voltage step depolarizations in control (C) and SCZD (D) neurons (command voltage varied from β20 to +30 mV in 5 mV increments when cells were voltage-clamped at β70 mV); action potentials evoked by somatic current injections in control (E) and SCZD (F) neurons (cells current-clamped at β60 mV, injected currents from 10 to 20 pA).(G) Representative traces of spontaneous postsynaptic currents in control and SCZD neurons.(H) Quantification of the frequency and amplitude of postsynaptic currents in control and SCZD neurons. βp < 0.05, ββp < 0.01; n = 40 control neurons, 42 SCZD neurons; two-tailed t test. Data are presented as mean Β± SEM.
| Name | Type |
|---|---|
| accutase | drug |
| action potential firing | phenotype |
| active neurons | phenotype |
| Alzheimer's disease | phenotype |
| AMPA receptor | drug |
| amyotrophic lateral sclerosis | phenotype |
| anticaudalizing factors local | drug |
| APV | drug |
| artificial cerebrospinal fluid (ACSF) | drug |
| ascorbic acid | drug |
| B27 supplement | drug |
| Bdnf | gene |
| bipolar patients local | cohort |
| brain development | phenotype |
| CA3 | anatomy |
| CA3 pyramidal neurons local | phenotype |
| calbindin-positive mature neurons local | phenotype |
| calcium | drug |
| calcium chloride | drug |
| calcium imaging local | drug |
| Calcium transient frequency local | phenotype |
| Calcium transients local | phenotype |
| calretinin-positive immature NPCs local | phenotype |
| cAMP | drug |
| CA subfields local | anatomy |
| cDNA | drug |
| cellular RNA local | drug |
| CNQX | drug |
| cocktail of factors local | drug |
| comparison group | cohort |
| control | cohort |
| control hiPSC-derived neurons local | cohort |
| control hiPSCs local | cohort |
| Control hiPSCs local | cohort |
| control individuals | cohort |
| control neurons local | cohort |
| Cortical pyramidal neurons local | anatomy |
| cyclic AMP | drug |
| cyclopamine local | drug |
| DCX | gene |
| Deficient granule neuron generation local | phenotype |
| Dendritic arborization oriented toward entorhinal inputs local | phenotype |
| dentate gyrus | anatomy |
| dentate gyrus precursors local | anatomy |
| depression | phenotype |
| developing forebrain local | anatomy |
| DG | anatomy |
| DG granule neuron local | phenotype |
| DG granule neurons local | phenotype |
| DKK1 local | drug |
| DKK1 | gene |
| DMEM/F12 | drug |
| DNase I | drug |
| donkey serum | drug |
| dorsal forebrain | anatomy |
| drugs | drug |
| EB local | drug |
| EBs local | cohort |
| eGFP | drug |
| EGTA | drug |
| Emx2 local | gene |
| EMX2 local | gene |
| entorhinal cortex | anatomy |
| epilepsy | phenotype |
| EPSCs | phenotype |
| fetal bovine serum | drug |
| FGF2 | drug |
| Fluo-4AM | drug |
| forebrain | anatomy |
| Forebrain interneurons local | anatomy |
| FOXG1 | gene |
| GABA | phenotype |
| GABA-excitatory state local | phenotype |
| GABA-inhibitory state local | phenotype |
| GCL local | anatomy |
| glucose | drug |
| glutamate | drug |
| glutamatergic neurons | phenotype |
| grafted neurons local | phenotype |
| Granular Cell Layer local | anatomy |
| granular layer | anatomy |
| granule neuron local | phenotype |
| hESC-derived hippocampal granule neurons local | anatomy |
| hESC-derived hippocampal neural networks local | cohort |
| hESC-derived hippocampal NPCs local | drug |
| hESCs | cohort |
| hippocampal astrocytes local | anatomy |
| Hippocampal dentate gyrus (DG) local | anatomy |
| hippocampal DG local | anatomy |
| hippocampal granule neuron local | anatomy |
| hippocampal granule neurons local | anatomy |
| hippocampal granule neurons local | phenotype |
| Hippocampal granule neurons local | anatomy |
| hippocampal neural progenitor local | phenotype |
| hippocampal NPCs local | anatomy |
| hippocampal NPCs local | cohort |
| hippocampal NPCs local | phenotype |
| hippocampal progenitors local | phenotype |
| hippocampus | anatomy |
| hippocampus-associated cognitive impairments local | phenotype |
| hiPSC | cohort |
| hiPSC-derived neurons | cohort |
| hiPSC lines | cohort |
| hiPSC model of SCZD local | cohort |
| hiPSCs | cohort |
| hPSCs | cohort |
| hPSCs local | phenotype |
| human embryonic stem cells | cohort |
| human hippocampal astrocytes local | drug |
| human neurofilament local | drug |
| immature dentate gyrus local | phenotype |
| Increased soma size | phenotype |
| ketamine | drug |
| K-gluconate | drug |
| laminin | drug |
| learning and memory | phenotype |
| lentivirus | drug |
| magnesium chloride | drug |
| MAP2 | gene |
| MAP2AB | gene |
| mossy fiber path local | anatomy |
| N2 local | drug |
| Na2-phosphocreatine local | drug |
| Na-ATP | drug |
| Na-GTP | drug |
| Na+/K+ currents local | drug |
| NeuN | drug |
| NEUROD1 | gene |
| neurodevelopmental component local | phenotype |
| neurodevelopmental diseases local | phenotype |
| neurogenesis | phenotype |
| neurological disorders | phenotype |
| neuronal activity | phenotype |
| neurons | phenotype |
| NMDAR | drug |
| NMDA receptor | drug |
| NOD-SCID mice | cohort |
| noggin local | gene |
| Noggin local | drug |
| NPC | drug |
| NPCs with anticaudalizing treatment local | cohort |
| NPCs without anticaudalizing treatment local | cohort |
| Oct4 | gene |
| P14 NOD-SCID pups local | cohort |
| Papain | drug |
| paraformaldehyde | drug |
| Parkinson's disease | phenotype |
| Pax6 | gene |
| PBS-glucose local | drug |
| perforant path | anatomy |
| Polarized morphology of immature neurons local | phenotype |
| polyornithine | drug |
| postmitotic neuronal marker local | phenotype |
| potassium | drug |
| potassium chloride | drug |
| Prox1 | gene |
| Prox1-EGFP reporter local | drug |
| Rabies virus local | drug |
| Reduced neuronal activity local | phenotype |
| Rock inhibitor | drug |
| saline | drug |
| SB431542 | drug |
| schizophrenia | phenotype |
| schizophrenic individuals local | cohort |
| SCZD hiPSC lines local | cohort |
| SCZD hiPSCs local | cohort |
| SCZD patient cohort local | cohort |
| SCZD patient hiPSCs local | cohort |
| Shh | gene |
| SLC12A5 | gene |
| Sodium | drug |
| sodium chloride | drug |
| Sox2 | gene |
| spinal motor neurons | anatomy |
| Spontaneous bursts of action potentials local | phenotype |
| spontaneous neurotransmitter release local | drug |
| spontaneous postsynaptic currents | phenotype |
| Subgranular zone | anatomy |
| Subgranular zone (SGZ) local | anatomy |
| sucrose | drug |
| Sustained potassium outward currents local | phenotype |
| SYBR green | drug |
| Synapsin-DsRed lentiviral vector local | drug |
| SZCD local | cohort |
| Tashiro et al., 2006 local | cohort |
| Tbr1 | gene |
| telencephalic neural precursors local | phenotype |
| tetrodotoxin | drug |
| Transient sodium inward currents local | phenotype |
| Transplanted Neurons local | phenotype |
| Triton X-100 | drug |
| TUBB3 | gene |
| Tuj1 | drug |
| Ventral midbrain dopaminergic neurons local | anatomy |
| VGLUT local | drug |
| wild-type | cohort |
| WNT | gene |
| Wnt3a local | drug |
| Wnt3a local | gene |
| WNT3A local | drug |
| WNT3A local | gene |
| WNT protein local | drug |
| xylazine | drug |
No uploaded files.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Dual inhibition of MAPK/ERK and BMP signaling induces entorhinal-like identity in mouse ESC-derived pallial progenitors. | Tonelli F et al. | β | 2025 | β |
| Dynamic Telomere Length Response to Neurodevelopmental Arsenic Exposure: Insights into Transcriptional Regulation and Neuronal Morphogenesis. | Tian C et al. | β | 2025 | β |
| Functional Analysis of Antipsychotics in Human iPSC-Based Neural Progenitor 2D and 3D Schizophrenia Models. | Farkas KG et al. | β | 2025 | β |
| Hippocampal Development and Epilepsy: Insights from Organoid Models. | Joo J et al. | β | 2025 | β |
| Aging phenotype in AD brain organoids: Track to success and challenges. | Hossain MK et al. | β | 2024 | β |
| Haloperidol, Olanzapine, and Risperidone Induce Morphological Changes in an In Vitro Model of Human Hippocampal Neurogenesis. | JezsΓ³ B et al. | β | 2024 | β |
| Human stem cell-based models to study synaptic dysfunction and cognition in schizophrenia: A narrative review. | Santarriaga S et al. | β | 2024 | β |
| In vitro human cell culture models in a bench-to-bedside approach to epilepsy. | DanaΔΓkovΓ‘ Ε et al. | β | 2024 | β |
| Patient-derived induced pluripotent stem cells: Tools to advance the understanding and drug discovery in Major Depressive Disorder. | Vaz A et al. | β | 2024 | β |
| Probing the biological consequences of a previously undescribed de novo mutation of ZMYND11 in a schizophrenia patient by CRISPR genome editing and induced pluripotent stem cell based in vitro disease-modeling. | Tordai C et al. | β | 2024 | β |
| Probing the molecular and cellular pathological mechanisms of schizophrenia using human induced pluripotent stem cell models. | Sebastian R et al. | β | 2024 | β |
| Protocol for transplantation of cells derived from human midbrain organoids into a Parkinson's disease mouse model to restore motor function. | Fu CL et al. | β | 2024 | β |
| Three-dimensional liquid metal-based neuro-interfaces for human hippocampal organoids. | Wu Y et al. | β | 2024 | β |
| Advancing preclinical models of psychiatric disorders with human brain organoid cultures. | Dixon TA et al. | β | 2023 | β |
| A Robust Pipeline for the Multi-Stage Accelerated Differentiation of Functional 3D Cortical Organoids from Human Pluripotent Stem Cells. | Whye D et al. | β | 2023 | β |
| Dysfunction of cAMP-Protein Kinase A-Calcium Signaling Axis in Striatal Medium Spiny Neurons: A Role in Schizophrenia and Huntington's Disease Neuropathology. | Fjodorova M et al. | β | 2023 | β |
| Information theory characteristics improve the prediction of lithium response in bipolar disorder patients using a support vector machine classifier. | Tripathi U et al. | β | 2023 | β |
| In vitro characterization on the role of APOE polymorphism in human hippocampal neurogenesis. | Lee H et al. | β | 2023 | β |
| [iPS cell technologies toward overcoming neurological diseases]. | Kimura T et al. | β | 2023 | β |
| JUN upregulation drives aberrant transposable element mobilization, associated innate immune response, and impaired neurogenesis in Alzheimer's disease. | Scopa C et al. | β | 2023 | β |
| Opportunities and limitations for studying neuropsychiatric disorders using patient-derived induced pluripotent stem cells. | Hong Y et al. | β | 2023 | β |
| A Learning Based Framework for Disease Prediction from Images of Human-Derived Pluripotent Stem Cells of Schizophrenia Patients. | Fularczyk N et al. | β | 2022 | β |
| Boosting Neurogenesis in the Adult Hippocampus Using Antidepressants and Mesenchymal Stem Cells. | Kot M et al. | β | 2022 | β |
| CRISPR/Cas-Based Approaches to Study Schizophrenia and Other Neurodevelopmental Disorders. | Kurishev AO et al. | β | 2022 | β |
| Culture of Human iPSC-Derived Motoneurons in Compartmentalized Microfluidic Devices and Quantitative Assays for Studying Axonal Phenotypes. | Garone MG et al. | β | 2022 | β |
| Current advancements of modelling schizophrenia using patient-derived induced pluripotent stem cells. | Dubonyte U et al. | β | 2022 | β |
| Disrupted mossy fiber connections from defective embryonic neurogenesis contribute to SOX11-associated schizophrenia. | Abulaiti X et al. | β | 2022 | β |
| Human-Induced Pluripotent Stem Cell Technology: Toward the Future of Personalized Psychiatry. | Alciati A et al. | β | 2022 | β |
| Microglia modulate proliferation, neurite generation and differentiation of human neural progenitor cells. | Lilienberg J et al. | β | 2022 | β |
| NXN Gene Epigenetic Changes in an Adult Neurogenesis Model of Alzheimer's Disease. | Blanco-Luquin I et al. | β | 2022 | β |
| Pluripotent stem cell strategies for rebuilding the human brain. | Limone F et al. | β | 2022 | β |
| Potential diagnostic biomarkers for schizophrenia. | Yue W et al. | β | 2022 | β |
| Research models of neurodevelopmental disorders: The right model in the right place. | Damianidou E et al. | β | 2022 | β |
| Using Stem Cell Models to Explore the Genetics Underlying Psychiatric Disorders: Linking Risk Variants, Genes, and Biology in Brain Disease. | Brennand KJ | β | 2022 | β |
| Xiaoyaosan ethyl acetate fraction alleviates depression-like behaviors in CUMS mice by promoting hippocampal neurogenesis via modulating the IGF-1RΞ²/PI3K/Akt signaling pathway. | Zeng J et al. | β | 2022 | β |
| Young transposable elements rewired gene regulatory networks in human and chimpanzee hippocampal intermediate progenitors. | Patoori S et al. | β | 2022 | β |
| Advances in development and application of human organoids. | Shankaran A et al. | β | 2021 | β |
| Applying stem cells and CRISPR engineering to uncover the etiology of schizophrenia. | Michael Deans PJ et al. | β | 2021 | β |
| A protein-centric view of in vitro biological model systems for schizophrenia. | Chandrasekaran A et al. | β | 2021 | β |
| Combined cellomics and proteomics analysis reveals shared neuronal morphology and molecular pathway phenotypes for multiple schizophrenia risk genes. | Rosato M et al. | β | 2021 | β |
| Deficient LEF1 expression is associated with lithium resistance and hyperexcitability in neurons derived from bipolar disorder patients. | Santos R et al. | β | 2021 | β |
| Emerging Opportunities in Human Pluripotent Stem-Cells Based Assays to Explore the Diversity of Botulinum Neurotoxins as Future Therapeutics. | Duchesne de Lamotte J et al. | β | 2021 | β |
| Human iPSC-Derived Glia as a Tool for Neuropsychiatric Research and Drug Development. | Heider J et al. | β | 2021 | β |
| Immunohistochemical evidence for adult human neurogenesis in health and disease. | Gault N et al. | β | 2021 | β |
| Induced pluripotent stem cells for 2D and 3D modelling the biological basis of schizophrenia and screening possible therapeutics. | Tomaskovic-Crook E et al. | β | 2021 | β |
| IQSEC2 mutation associated with epilepsy, intellectual disability, and autism results in hyperexcitability of patient-derived neurons and deficient synaptic transmission. | Brant B et al. | β | 2021 | β |
| Making Sense of Patient-Derived iPSCs, Transdifferentiated Neurons, Olfactory Neuronal Cells, and Cerebral Organoids as Models for Psychiatric Disorders. | Unterholzner J et al. | β | 2021 | β |
| Maternal immune activation primes deficiencies in adult hippocampal neurogenesis. | Couch ACM et al. | β | 2021 | β |
| Pharmacological Modulation of Neurite Outgrowth in Human Neural Progenitor Cells by Inhibiting Non-muscle Myosin II. | Lilienberg J et al. | β | 2021 | β |
| Pharmacological rescue in patient iPSC and mouse models with a rare DISC1 mutation. | Kim NS et al. | β | 2021 | β |
| Systematic Review of the Neural Effect of Electroconvulsive Therapy in Patients with Schizophrenia: Hippocampus and Insula as the Key Regions of Modulation. | Moon SY et al. | β | 2021 | β |
| The Perspectives of Early Diagnosis of Schizophrenia Through the Detection of Epigenomics-Based Biomarkers in iPSC-Derived Neurons. | Lee D et al. | β | 2021 | β |
| The potential of induced pluripotent stem cells for discriminating neurodevelopmental disorders. | Stock R et al. | β | 2021 | β |
| The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study. | Onwordi EC et al. | β | 2021 | β |
| Thifluzamide exposure induced neuro-endocrine disrupting effects in zebrafish (Danio rerio). | Yang Y et al. | β | 2021 | β |
| Adult Hippocampal Neurogenesis in Major Depressive Disorder and Alzheimer's Disease. | Berger T et al. | β | 2020 | β |
| A Physiological Instability Displayed in Hippocampal Neurons Derived From Lithium-Nonresponsive Bipolar Disorder Patients. | Stern S et al. | β | 2020 | β |
| Apolipoprotein E expression pattern in human induced pluripotent stem cells during <i>in vitro</i> neural induction. | Lee H et al. | β | 2020 | β |
| Are CB2 Receptors a New Target for Schizophrenia Treatment? | Cortez IL et al. | β | 2020 | β |
| CRISPR-based functional evaluation of schizophrenia risk variants. | Rajarajan P et al. | β | 2020 | β |
| Developmental excitation-inhibition imbalance underlying psychoses revealed by single-cell analyses of discordant twins-derived cerebral organoids. | Sawada T et al. | β | 2020 | β |
| Dopamine and glutamate in schizophrenia: biology, symptoms and treatment. | McCutcheon RA et al. | β | 2020 | β |
| Functional Comparison of Blood-Derived Human Neural Progenitor Cells. | SzabΓ³ E et al. | β | 2020 | β |
| Human iPSC-Derived Hippocampal Spheroids: An Innovative Tool for Stratifying Alzheimer Disease Patient-Specific Cellular Phenotypes and Developing Therapies. | Pomeshchik Y et al. | β | 2020 | β |
| Increased Neural Progenitor Proliferation in a hiPSC Model of Autism Induces Replication Stress-Associated Genome Instability. | Wang M et al. | β | 2020 | β |
| Integrating CRISPR Engineering and hiPSC-Derived 2D Disease Modeling Systems. | Rehbach K et al. | β | 2020 | β |
| Integration of CRISPR-engineering and hiPSC-based models of psychiatric genomics. | Matos MR et al. | β | 2020 | β |
| Investigation of de novo mutations in a schizophrenia case-parent trio by induced pluripotent stem cell-based in vitro disease modeling: convergence of schizophrenia- and autism-related cellular phenotypes. | Hathy E et al. | β | 2020 | β |
| Investigation of Schizophrenia with Human Induced Pluripotent Stem Cells. | Powell SK et al. | β | 2020 | β |
| Long-term effects of stress early in life on microRNA-30a and its network: Preventive effects of lurasidone and potential implications for depression vulnerability. | Cattaneo A et al. | β | 2020 | β |
| Mechanisms Underlying the Hyperexcitability of CA3 and Dentate Gyrus Hippocampal Neurons Derived From Patients With Bipolar Disorder. | Stern S et al. | β | 2020 | β |
| Modeling Brain Disorders Using Induced Pluripotent Stem Cells. | Vadodaria KC et al. | β | 2020 | β |
| Modeling genetic epilepsies in a dish. | Niu W et al. | β | 2020 | β |
| Modeling neuropsychiatric disorders using human induced pluripotent stem cells. | Wang M et al. | β | 2020 | β |
| Modeling Psychiatric Disorder Biology with Stem Cells. | Das D et al. | β | 2020 | β |
| Neuronal Differentiation of Induced Pluripotent Stem Cells from Schizophrenia Patients in Two-Dimensional and in Three-Dimensional Cultures Reveals Increased Expression of the Kv4.2 Subunit DPP6 That Contributes to Decreased Neuronal Activity. | Naujock M et al. | β | 2020 | β |
| Organoid and pluripotent stem cells in Parkinson's disease modeling: an expert view on their value to drug discovery. | Marotta N et al. | β | 2020 | β |
| Parvalbumin Interneuron Activation-Dependent Adult Hippocampal Neurogenesis Is Required for Treadmill Running to Reverse Schizophrenia-Like Phenotypes. | Yi Y et al. | β | 2020 | β |
| Single-cell and spatial transcriptomics enables probabilistic inference of cell type topography. | Andersson A et al. | β | 2020 | β |
| The fusiform gyrus exhibits an epigenetic signature for Alzheimer's disease. | Ma D et al. | β | 2020 | β |
| Towards an understanding of the physical activity-BDNF-cognition triumvirate: A review of associations and dosage. | Walsh EI et al. | β | 2020 | β |
| Using Two- and Three-Dimensional Human iPSC Culture Systems to Model Psychiatric Disorders. | Christian KM et al. | β | 2020 | β |
| Vascularized human cortical organoids (vOrganoids) model cortical development in vivo. | Shi Y et al. | β | 2020 | β |
| All Together Now: Modeling the Interaction of Neural With Non-neural Systems Using Organoid Models. | Chukwurah E et al. | β | 2019 | β |
| Application of human pluripotent stem cells and pluripotent stem cell-derived cellular models for assessing drug toxicity. | ApΓ‘ti Γ et al. | β | 2019 | β |
| Contribution of induced pluripotent stem cell technologies to the understanding of cellular phenotypes in schizophrenia. | Balan S et al. | β | 2019 | β |
| Expression of neurogenic markers in Alzheimer's disease: a systematic review and metatranscriptional analysis. | Gatt A et al. | β | 2019 | β |
| Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes. | Song M et al. | β | 2019 | β |
| Modeling Human Brain Circuitry Using Pluripotent Stem Cell Platforms. | Hartlaub AM et al. | β | 2019 | β |
| Modeling neuronopathic storage diseases with patient-derived culture systems. | Zunke F et al. | β | 2019 | β |
| Modeling Psychiatric Diseases with Induced Pluripotent Stem Cells. | van Hugte E et al. | β | 2019 | β |
| New considerations for hiPSC-based models of neuropsychiatric disorders. | Hoffman GE et al. | β | 2019 | β |
| Pluripotent Stem Cells for Brain Repair: Protocols and Preclinical Applications in Cortical and Hippocampal Pathologies. | Alia C et al. | β | 2019 | β |
| Primary Cilia-An Underexplored Topic in Major Mental Illness. | Pruski M et al. | β | 2019 | β |
| Progress in iPSC-Based Modeling of Psychiatric Disorders. | Hoffmann A et al. | β | 2019 | β |
| Single-cell multimodal transcriptomics to study neuronal diversity in human stem cell-derived brain tissue and organoid models. | van den Hurk M et al. | β | 2019 | β |
| Spatial mapping of cell types by integration of transcriptomics data | Andersson A et al. | β | 2019 | β |
| Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models. | Logan S et al. | β | 2019 | β |
| The role of adult hippocampal neurogenesis in brain health and disease. | Toda T et al. | β | 2019 | β |
| Adult stem cells in psychiatric disorders - New discoveries in peripheral blood. | Kucharska-Mazur J et al. | β | 2018 | β |
| Cell-Biological Requirements for the Generation of Dentate Gyrus Granule Neurons. | Hatami M et al. | β | 2018 | β |
| Combining Optical Approaches with Human Inducible Pluripotent Stem Cells in G Protein-Coupled Receptor Drug Screening and Development. | Bourque K et al. | β | 2018 | β |
| Direct conversion of human pluripotent stem cells into cranial motor neurons using a piggyBac vector. | De Santis R et al. | β | 2018 | β |
| Efficient Generation of CA3 Neurons from Human Pluripotent Stem Cells Enables Modeling of Hippocampal Connectivity InΒ Vitro. | Sarkar A et al. | β | 2018 | β |
| Expression-based drug screening of neural progenitor cells from individuals with schizophrenia. | Readhead B et al. | β | 2018 | β |
| Genetics of Alcohol Use Disorder: A Role for Induced Pluripotent Stem Cells? | Prytkova I et al. | β | 2018 | β |
| HippoCA3mpal Stem Cell Models Expose Dysfunctional Circuits in Schizophrenia. | Johnstone M et al. | β | 2018 | β |
| HMGB2 expression is associated with transition from a quiescent to an activated state of adult neural stem cells. | Kimura A et al. | β | 2018 | β |
| Human Hippocampal Neurogenesis Persists throughout Aging. | Boldrini M et al. | β | 2018 | β |
| Induced pluripotent stem cells (iPSCs) as model to study inherited defects of neurotransmission in inborn errors of metabolism. | Jung-Klawitter S et al. | β | 2018 | β |
| Induced Pluripotent Stem Cells Reveal Common Neurodevelopmental Genome Deprograming in Schizophrenia. | Narla ST et al. | β | 2018 | β |
| Inhibition of DNA methyltransferase leads to increased genomic 5-hydroxymethylcytosine levels in hematopoietic cells. | VetΕ B et al. | β | 2018 | β |
| Inhibition of STEP<sub>61</sub> ameliorates deficits in mouse and hiPSC-based schizophrenia models. | Xu J et al. | β | 2018 | β |
| JNK1 controls adult hippocampal neurogenesis and imposes cell-autonomous control of anxiety behaviour from the neurogenic niche. | Mohammad H et al. | β | 2018 | β |
| Neural stem cell heterogeneity in the mammalian forebrain. | Adams KV et al. | β | 2018 | β |
| Neurons derived from patients with bipolar disorder divide into intrinsically different sub-populations of neurons, predicting the patients' responsiveness to lithium. | Stern S et al. | β | 2018 | β |
| Neurons Generated by Mouse ESCs with Hippocampal or Cortical Identity Display Distinct Projection Patterns When Co-transplanted in the Adult Brain. | Terrigno M et al. | β | 2018 | β |
| Neuroprotective Activities of Heparin, Heparinase III, and Hyaluronic Acid on the A<i>Ξ²</i>42-Treated Forebrain Spheroids Derived from Human Stem Cells. | Bejoy J et al. | β | 2018 | β |
| Studying and modulating schizophrenia-associated dysfunctions of oligodendrocytes with patient-specific cell systems. | Raabe FJ et al. | β | 2018 | β |
| Synaptic dysfunction in neurodegenerative and neurodevelopmental diseases: an overview of induced pluripotent stem-cell-based disease models. | Taoufik E et al. | β | 2018 | β |
| Tracing Early Neurodevelopment in Schizophrenia with Induced Pluripotent Stem Cells. | Ahmad R et al. | β | 2018 | β |
| Uncovering True Cellular Phenotypes: Using Induced Pluripotent Stem Cell-Derived Neurons to Study Early Insults in Neurodevelopmental Disorders. | Fink JJ et al. | β | 2018 | β |
| Why has adult hippocampal neurogenesis had so little impact on psychiatry? | Liu KY et al. | β | 2018 | β |
| Adult hippocampal neurogenesis and cognitive flexibility - linking memory and mood. | Anacker C et al. | β | 2017 | β |
| Application of induced pluripotent stem cells to understand neurobiological basis of bipolar disorder and schizophrenia. | Liu YN et al. | β | 2017 | β |
| Are reprogrammed cells a useful tool for studying dopamine dysfunction in psychotic disorders? A review of the current evidence. | Sauerzopf U et al. | β | 2017 | β |
| Cellular models to study schizophrenia: A systematic review. | Seshadri M et al. | β | 2017 | β |
| Cerebral organoids reveal early cortical maldevelopment in schizophrenia-computational anatomy and genomics, role of FGFR1. | Stachowiak EK et al. | β | 2017 | β |
| Common developmental genome deprogramming in schizophrenia - Role of Integrative Nuclear FGFR1 Signaling (INFS). | Narla ST et al. | β | 2017 | β |
| Concise Review: Induced Pluripotent Stem Cell Models for Neuropsychiatric Diseases. | Adegbola A et al. | β | 2017 | β |
| Deriving, regenerating, and engineering CNS tissues using human pluripotent stem cells. | Lemke KA et al. | β | 2017 | β |
| Differentiation of Inflammation-Responsive Astrocytes from Glial Progenitors Generated from Human Induced Pluripotent Stem Cells. | Santos R et al. | β | 2017 | β |
| Establishment of a novel three-dimensional primary culture model for hippocampal neurogenesis. | Usui T et al. | β | 2017 | β |
| Evaluating Synthetic Activation and Repression of Neuropsychiatric-Related Genes in hiPSC-Derived NPCs, Neurons, and Astrocytes. | Ho SM et al. | β | 2017 | β |
| Examining FKBP5 mRNA expression in human iPSC-derived neural cells. | Lieberman R et al. | β | 2017 | β |
| Genetically-Informed Patient Selection for iPSC Studies of Complex Diseases May Aid in Reducing Cellular Heterogeneity. | Hoekstra SD et al. | β | 2017 | β |
| Human induced pluripotent stem cells for modelling neurodevelopmental disorders. | Ardhanareeswaran K et al. | β | 2017 | β |
| Modeling neurodevelopmental and psychiatric diseases with human iPSCs. | Wen Z | β | 2017 | β |
| Molecular Mechanisms of Bipolar Disorder: Progress Made and Future Challenges. | Kim Y et al. | β | 2017 | β |
| Prospects for Modeling Abnormal Neuronal Function in Schizophrenia Using Human Induced Pluripotent Stem Cells. | Prytkova I et al. | β | 2017 | β |
| Schizophrenia and neurogenesis: A stem cell approach. | Iannitelli A et al. | β | 2017 | β |
| Stem cell-derived neurons in the development of targeted treatment for schizophrenia and bipolar disorder. | Watmuff B et al. | β | 2017 | β |
| Synaptic activity: An emerging player in schizophrenia. | Sarkar A et al. | β | 2017 | β |
| Targeting Adult Neurogenesis to Optimize Hippocampal Circuits in Aging. | McAvoy KM et al. | β | 2017 | β |
| The Importance of Non-neuronal Cell Types in hiPSC-Based Disease Modeling and Drug Screening. | Gonzalez DM et al. | β | 2017 | β |
| Understanding neurodevelopmental disorders using human pluripotent stem cell-derived neurons. | Tamburini C et al. | β | 2017 | β |
| Venlafaxine in Embryos Stimulates Neurogenesis and Disrupts Larval Behavior in Zebrafish. | Thompson WA et al. | β | 2017 | β |
| What if it was easier to prevent schizophrenia than to treat it? | J Brennand K | β | 2017 | β |
| A Dishful of a Troubled Mind: Induced Pluripotent Stem Cells in Psychiatric Research. | KΓ‘lmΓ‘n S et al. | β | 2016 | β |
| Adult Hippocampal Neurogenesis, Fear Generalization, and Stress. | Besnard A et al. | β | 2016 | β |
| Adult Neurogenesis in the Hippocampus: From Stem Cells to Behavior. | GonΓ§alves JT et al. | β | 2016 | β |
| Altering the course of schizophrenia: progress and perspectives. | Millan MJ et al. | β | 2016 | β |
| Analysis of induced pluripotent stem cells carrying 22q11.2 deletion. | Toyoshima M et al. | β | 2016 | β |
| A role for miR-19 in the migration of adult-born neurons and schizophrenia. | Han J et al. | β | 2016 | β |
| Concise Review: Progress and Challenges in Using Human Stem Cells for Biological and Therapeutics Discovery: Neuropsychiatric Disorders. | Panchision DM | β | 2016 | β |
| Current Opinion on the Role of Neurogenesis in the Therapeutic Strategies for Alzheimer Disease, Parkinson Disease, and Ischemic Stroke; Considering Neuronal Voiding Function. | Han MH et al. | β | 2016 | β |
| Directed differentiation of basal forebrain cholinergic neurons from human pluripotent stem cells. | Hu Y et al. | β | 2016 | β |
| Disease signatures for schizophrenia and bipolar disorder using patient-derived induced pluripotent stem cells. | Watmuff B et al. | β | 2016 | β |
| Dysregulation of miRNA-9 in a Subset of Schizophrenia Patient-Derived Neural Progenitor Cells. | Topol A et al. | β | 2016 | β |
| Engineering of Adult Neurogenesis and Gliogenesis. | Berninger B et al. | β | 2016 | β |
| Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience. | Mertens J et al. | β | 2016 | β |
| Functional Characterization of Acetylcholine Receptors Expressed in Human Neurons Differentiated from Hippocampal Neural Stem/Progenitor Cells. | Fukushima K et al. | β | 2016 | β |
| Functional Implications of miR-19 in the Migration of Newborn Neurons in the Adult Brain. | Han J et al. | β | 2016 | β |
| High-throughput compound evaluation on 3D networks of neurons and glia in a microfluidic platform. | Wevers NR et al. | β | 2016 | β |
| Human Inducible Pluripotent Stem Cells and Autism Spectrum Disorder: Emerging Technologies. | Nestor MW et al. | β | 2016 | β |
| Induced Pluripotent Stem Cells as a Novel Tool in Psychiatric Research. | Kim S et al. | β | 2016 | β |
| Kaleidoscope. | Tracy DK et al. | β | 2016 | β |
| L1-associated genomic regions are deleted in somatic cells of the healthy human brain. | Erwin JA et al. | β | 2016 | β |
| Linking adult hippocampal neurogenesis with human physiology and disease. | Bowers M et al. | β | 2016 | β |
| Modeling psychiatric disorders: from genomic findings to cellular phenotypes. | Falk A et al. | β | 2016 | β |
| Modeling psychiatric disorders with patient-derived iPSCs. | Wen Z et al. | β | 2016 | β |
| Modeling synaptogenesis in schizophrenia and autism using human iPSC derived neurons. | Habela CW et al. | β | 2016 | β |
| Neural Subtype Specification from Human Pluripotent Stem Cells. | Tao Y et al. | β | 2016 | β |
| Neuroplasticity and Clinical Practice: Building Brain Power for Health. | Shaffer J | β | 2016 | β |
| Stem and Progenitor Cell-Based Therapy of the Central Nervous System: Hopes, Hype, and Wishful Thinking. | Goldman SA | β | 2016 | β |
| A dangerous method? The use of induced pluripotent stem cells as a model for schizophrenia. | Jacobs BM | β | 2015 | β |
| Advances in reprogramming-based study of neurologic disorders. | Nityanandam A et al. | β | 2015 | β |
| A guide to generating and using hiPSC derived NPCs for the study of neurological diseases. | Topol A et al. | β | 2015 | β |
| Altered WNT Signaling in Human Induced Pluripotent Stem Cell Neural Progenitor Cells Derived from Four Schizophrenia Patients. | Topol A et al. | β | 2015 | β |
| Being human: The role of pluripotent stem cells in regenerative medicine and humanizing Alzheimer's disease models. | Sproul AA | β | 2015 | β |
| Cellular models to study bipolar disorder: A systematic review. | Viswanath B et al. | β | 2015 | β |
| Creating Patient-Specific Neural Cells for the In Vitro Study of Brain Disorders. | Brennand KJ et al. | β | 2015 | β |
| Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder. | Mertens J et al. | β | 2015 | β |
| From "directed differentiation" to "neuronal induction": modeling neuropsychiatric disease. | Ho SM et al. | β | 2015 | β |
| Generation of functional hippocampal neurons from self-organizing human embryonic stem cell-derived dorsomedial telencephalic tissue. | Sakaguchi H et al. | β | 2015 | β |
| Genomic DISC1 Disruption in hiPSCs Alters Wnt Signaling and Neural Cell Fate. | Srikanth P et al. | β | 2015 | β |
| Increased abundance of translation machinery in stem cell-derived neural progenitor cells from four schizophrenia patients. | Topol A et al. | β | 2015 | β |
| Moving stem cells to the clinic: potential and limitations for brain repair. | Steinbeck JA et al. | β | 2015 | β |
| Probing disorders of the nervous system using reprogramming approaches. | Ichida JK et al. | β | 2015 | β |
| Reprogramming patient-derived cells to study the epilepsies. | Parent JM et al. | β | 2015 | β |
| Spatial and temporal control of cell aggregation efficiently directs human pluripotent stem cells towards neural commitment. | Miranda CC et al. | β | 2015 | β |
| The proteome of schizophrenia. | Nascimento JM et al. | β | 2015 | β |
| Using Patient-Derived Induced Pluripotent Stem Cells to Model and Treat Epilepsies. | Du X et al. | β | 2015 | β |
| Adult neurogenesis: bridging the gap between mice and humans. | Jessberger S et al. | β | 2014 | β |
| Electrical maturation of neurons derived from human embryonic stem cells. | Telias M et al. | β | 2014 | β |
| Evolving toward a human-cell based and multiscale approach to drug discovery for CNS disorders. | Schadt EE et al. | β | 2014 | β |
| How to make a hippocampal dentate gyrus granule neuron. | Yu DX et al. | β | 2014 | β |
| Human iPSC neurons display activity-dependent neurotransmitter secretion: aberrant catecholamine levels in schizophrenia neurons. | Hook V et al. | β | 2014 | β |
| Human stem cell models of dementia. | Livesey FJ | β | 2014 | β |
| Synaptic dysregulation in a human iPS cell model of mental disorders. | Wen Z et al. | β | 2014 | β |